Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer-Reference-Cited by-同舟云学术

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

Published:2015-03-09 Issue:7547 Volume:520 Page:373-377
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Twyman-Saint Victor Christina,Rech Andrew J.,Maity Amit,Rengan Ramesh,Pauken Kristen E.,Stelekati Erietta,Benci Joseph L.,Xu Bihui,Dada Hannah,Odorizzi Pamela M.,Herati Ramin S.,Mansfield Kathleen D.,Patsch Dana,Amaravadi Ravi K.,Schuchter Lynn M.,Ishwaran Hemant,Mick Rosemarie,Pryma Daniel A.,Xu Xiaowei,Feldman Michael D.,Gangadhar Tara C.,Hahn Stephen M.,Wherry E. John,Vonderheide Robert H.,Minn Andy J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature14292.pdf

Reference33 articles.

1. Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nature Rev. Cancer 12, 252–264 (2012)

2. Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711–723 (2010)

3. Hamid, O. et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N. Engl. J. Med. 369, 134–144 (2013)

4. Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443–2454 (2012)

5. Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455–2465 (2012)

Cited by 1999 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders;Oral Oncology;2024-11

2. Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitors;Radiotherapy and Oncology;2024-10

3. Synthetic vectors for activating the driving axis of ferroptosis;Nature Communications;2024-09-10

4. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;CLIN LUNG CANCER;2024

5. Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies;Biomedicine & Pharmacotherapy;2024-09